Abstract
The lung is protected by multiple mechanisms, but the primary defense is mucociliary clearance (MCC). MCC is responsible for removing noxious particulates that may reduce lung health, but it can also clear inhaled pharmaceuticals. Effective MCC relies on the correct ciliary structure and pattern of movement, combined with mucus rheology characteristics, that together facilitate particle capture and transport. Abnormalities in these result in muco-obstructive disease.
| Original language | English |
|---|---|
| Title of host publication | Inhaled Medicines |
| Subtitle of host publication | Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches |
| Editors | Stavros Kassinos, Per Backman, Joy Conway, Anthony J. Hickey |
| Place of Publication | London, United Kingdom |
| Publisher | Elsevier |
| Chapter | 8 |
| Pages | 197-223 |
| Number of pages | 27 |
| ISBN (Electronic) | 9780128149744 |
| DOIs | |
| Publication status | Published - 2021 |
Keywords
- Airways
- Computed tomography
- Muco-obstructive disease
- Mucociliary clearance
- Non-absorptive clearance
- Optical coherence tomography
- Respiratory system
- Synchrotron
- X-ray